Francisco José L. J.
- Country
- Spain
- Department
- Hematology
Research Overview
- Phase Ib Study of TU7710: Safety, Pharmacokinetics, and Pharmacodynamics in Patients with Hemophilia A or B
- A Randomized Non-Inferiority Study Comparing 7-Day versus 14-Day Antibiotic Treatment with Ciprofloxacin or Ceftriaxone for Graft Pyelonephritis in Kidney Transplant Recipients
- Phase III Randomized Open‑Label Trial of Subcutaneous NXT007 Prophylaxis versus Intravenous Factor VIII Prophylaxis in Patients with Hemophilia A without Inhibitors
Data & Insights
Has run more than one trial at 31 of 101 partner sites.
Specializations
Oncology – Advanced Solid Tumors
Leadership in clinical programs targeting diverse solid tumors with emphasis on molecularly defined subpopulations.
- non‑small cell lung cancer
- breast cancer
- colorectal carcinoma
- melanoma
- renal cell carcinoma
Research integrates targeted agents, immunotherapies and biomarker‑guided strategies to improve outcomes across these malignancies.
Hematologic Malignancies
Extensive involvement in trials for blood‑based cancers, ranging from acute to chronic entities.
- acute myeloid leukemia
- myelodysplastic syndrome
- chronic lymphocytic leukemia
- multiple myeloma
- diffuse large B‑cell lymphoma
Therapeutic focus includes novel agents, cellular therapies and combination regimens for refractory disease.
Autoimmune & Inflammatory Disorders
Active investigation of immune‑mediated conditions affecting skin, joints and systemic organs.
- rheumatoid arthritis
- psoriasis
- atopic dermatitis
- systemic lupus erythematosus
- inflammatory bowel disease
Studies emphasize biologic modulation, cytokine inhibition and precision immunotherapy.
Metabolic & Respiratory Disorders
Research addresses chronic metabolic and airway diseases with high prevalence in adult populations.
- obstructive sleep apnea
- obesity
- type 2 diabetes mellitus
- asthma
- chronic obstructive pulmonary disease
Interventions explore metabolic control, weight‑management strategies and advanced inhaled therapeutics.
Cardiovascular & Thrombotic Conditions
Focused on cardiovascular risk reduction and management of acute vascular events.
- atrial fibrillation
- heart failure
- acute coronary syndrome
- ischemic stroke
- atherosclerotic cardiovascular disease
Clinical work includes antithrombotic therapies, novel anticoagulants and disease‑modifying cardiovascular agents.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.